Thomas Heldt is Associate Professor of Electrical and Biomedical Engineering in the Department of Electrical Engineering and Computer Science at MIT, and a Principal Investigator at MIT's Research Laboratory of Electronics. He leads the Integrative Neuromonitoring and Critical Care Informatics Group and serves as Associate Director of the Institute for Medical Engineering and Science. Research focuses on: Noninvasive intracranial pressure monitoring Computational models of cerebrovascular dynamics Sepsis detection algorithms Wearable physiological monitoring Clinical decision support systems Recent publications (2022-2024) demonstrate advances in hemodynamic modeling, diagnostic algorithms for critical care, and AI applications for physiological monitoring. Key innovations include open cranium models for intracranial hypertension studies, deep learning frameworks for fatigue assessment, and mobile-based neurocognitive tracking. Professor Heldt collaborates with Boston Children's Hospital, Beth Israel Deaconess Medical Center, and Boston Medical Center to translate research into clinical practice. His work has been recognized through the W.M. Keck Career Development Professorship and IEEE EMBS Distinguished Lectureship.
Dr. Jean King is an Adjunct Professor at UMass Chan Medical School's Department of Psychiatry and Behavioral Sciences, affiliated with the T.H. Chan School of Medicine. She holds dual roles in the Radiology department as part of her other academic positions. Her educational background includes a BS in Biology from Saint Francis College, an MS in Cell Biology from City University of New York, and a PhD in Biology/Neurophysiology from New York University. Her research focuses on translational neuroimaging to study brain alterations linked to stress-related conditions such as addiction, ADHD, and traumatic brain injury (TBI). Recent work extends to co-morbid mental health disorders and stress mitigation strategies like mindfulness. Her lab employs both preclinical models and clinical populations to explore neural mechanisms of emotional/cognitive processing under stress. Key publications (2014–2020) investigate neural connectivity in ADHD, nicotine dependence pathways, concussion bioenergetics, and mindfulness-based interventions. Dr. King has received over 20 awards including the NIH-funded NCCIH grant (2017–2020), multiple mentorship accolades, and the University of Massachusetts President’s Public Service Award. Her work bridges neuroscience, psychiatry, and clinical applications, with a focus on translational research. Lab activities include multi-modal imaging studies (fMRI, MRS) and behavioral assessments in both human and animal models. Current projects explore the neurobiological basis of stress resilience and cognitive recovery post-TBI. Collaborations span addiction medicine, mental health, and neurodegenerative disease research.
Prof. Fahrettin Yıldız is a full-time Professor at Gaziantep University's Faculty of Medicine, Department of General Surgery, specializing in hepatobiliary surgery, organ transplantation, and ischemia-reperfusion pathology. He completed his medical degree at Ege University Faculty of Medicine (1993-1999) and surgical specialization at Aegean Medical Faculty (2012-2016). His academic career includes promotions from Assistant Professor to Professor through positions at Harran University and Gaziantep University. Research interests span: Transplant Surgery : Innovations in living-donor techniques for liver/kidney transplantation Ischemia-Reperfusion Injury : Protective effects of flavonoids, herbal agents (Nigella sativa), and amino acids Minimally Invasive Approaches : Laparoscopic techniques for appendectomy/cholecystectomy Surgical Oncology : Management of breast, gastric, and pancreatic malignancies His publications demonstrate a strong focus on experimental and clinical surgery, with recurring themes in oxidative stress mitigation, novel anastomosis techniques, and management of surgical complications. Recent work (2024) addresses persistent biliary fistulas, while transplantation-related studies explore biomarkers for graft survival. Prof. Yıldız has supervised 5 medical specialization theses and actively contributes to national/international surgical societies including the Turkish Organ Transplantation Coordination Association and Liver Transplantation Association. He maintains involvement in ongoing research on SGLT2 inhibitors in transplant recipients and laparoscopic donor nephrectomy outcomes.
Véronique Cortier is a CNRS Research Director at the Lorraine Laboratory for Research in Computer Science and its Applications (Loria) in Nancy, France. She specializes in formal verification of security systems, particularly electronic voting protocols, and has co-authored over 80 publications. Her work bridges symbolic and computational models for cryptographic security. Notable roles include serving as program chair for CSF 2012-2013 and editorial duties for journals like TISSEC/TOPS. She leads the PEPR Cybersecurity Security Verification Protocol (SVP) (2022–2028) and has received grants from ANR, ERC, and PHC Alliance. Her research focuses on ensuring vote secrecy and verifiability in e-voting systems like Belenios , which has been used in 3,500+ elections. She also emphasizes transparency and public engagement through books and talks. 2022 : CNRS Silver Medal 2021 : Swiss Post bug bounty 2015 : Inria-French Académie des sciences Young Researcher Award Current advisees: Léo Louistisserand and Florian Moser.
Mark D. Krieger, MD is Professor of Clinical Neurological Surgery at the Keck School of Medicine of the University of Southern California, where he also serves as Senior Vice President and Surgeon-in-Chief, and Medical Director of the Neurological Institute at Children's Hospital Los Angeles (CHLA). With over 30 years of academic and clinical experience, Dr. Krieger specializes in pediatric neurosurgery with a focus on complex conditions including hydrocephalus, Chiari malformation, and pediatric brain tumors. Dr. Krieger's research spans multiple domains within pediatric neurosurgery. His primary interests include hydrocephalus management and shunt-related complications, Chiari malformation and syringomyelia, pediatric brain tumors and their molecular characteristics, and surgical outcomes research. As a principal investigator in the Hydrocephalus Clinical Research Network and the Park-Reeves Syringomyelia Research Consortium, he has led numerous multi-institutional studies examining best practices and outcomes in pediatric neurosurgical conditions. Analyzing his recent publication trends reveals a strong emphasis on evidence-based approaches to pediatric neurosurgical conditions. His work frequently addresses health disparities in neurosurgical outcomes, particularly racial disparities in hydrocephalus management. Dr. Krieger has made significant contributions to understanding shunt complications, optimizing timing of interventions in hydrocephalus, and advancing the molecular characterization of pediatric brain tumors. His research consistently bridges clinical practice with scientific investigation to improve outcomes for children with neurological conditions. Dr. Krieger maintains active involvement in surgical education and training, having contributed to studies on pediatric neurosurgery residency training in the United States. His leadership extends to national organizations, including the American Society of Pediatric Neurosurgeons, where he has provided guidance during critical periods such as the COVID-19 pandemic. His work with the Hydrocephalus Clinical Research Network has established important quality improvement initiatives, including the role of antibiotic-impregnated catheters in reducing shunt infections.
Dr. Gunjan Y. Parikh serves as an Associate Professor in the Department of Neurology at the University of Maryland School of Medicine, where she also functions as the Medical Director of the UMMC Neuro Critical Care Unit. Her clinical practice focuses on the intersection of neurology and critical care medicine, with particular expertise in managing patients with acute neurological emergencies including traumatic brain injury, intracerebral hemorrhage, and subarachnoid hemorrhage. Dr. Parikh completed her undergraduate education with a BA in Biochemistry from The University of Texas at Austin, followed by her MD from Texas A&M College of Medicine. Her clinical training includes an Internal Medicine internship at St. Vincent's Hospital - Manhattan, Neurology residency at Barrow Neurological Institute at Saint Joseph's Hospital and Medical Center (where she also served as Chief Resident), and specialized fellowship training in Neurocritical Care/Vascular Neurology at Columbia University Medical Center/Weill Cornell Medical Center. She further enhanced her research skills through an NINDS Research Fellowship in Neuroimaging at the National Institutes of Health. Her research program centers on identifying biomarkers during the resuscitation phase of patients with acute brain injuries that determine lesion repair, restoration of function, and recovery of consciousness. This work has led to significant contributions in characterizing the MRI signature of primary microvascular injury after head trauma and other acute brain injuries through both in vivo and ex vivo investigations. Her lab integrates multimodality monitoring with advanced neuroimaging techniques to translate findings to clinical care and develop outcome measures for clinical trials targeting currently untreatable aspects of brain injury such as demyelination and neurodegeneration. Analysis of Dr. Parikh's recent publications reveals a strong focus on translational neuroscience with emphasis on neuroimaging techniques, biomarker discovery, and clinical applications for acute brain injury management. Her work spans from basic science investigations of microvascular injury to clinical studies on patient outcomes, with particular attention to traumatic brain injury, intracerebral hemorrhage, and subarachnoid hemorrhage. Recent publications demonstrate increasing integration of data science approaches for predicting neurological deterioration and developing automated clinical assessment tools. Fellow of the Neurocritical Care Society (2024) Member, American Academy of Neurology Member, Neurocritical Care Society Member, National Neurotrauma Society Dr. Parikh serves as Site Co-PI for the DISCOVERY study (Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on Recovery) under NINDS/NIA U19 NS115388, and as SubK site-PI for the REACH-ICH study (Race/Ethnicity, Hypertension and Prevention of VCID and Stroke after Intracerebral Hemorrhage) under NINDS/NIH 5R01NS093870-08. Her research has been featured in multiple media outlets including MD Edge Psychiatry, News Medical, and SciTech Daily, highlighting her contributions to understanding vascular injury in traumatic brain injury. As Medical Director of the UMMC Neuro Critical Care Unit, Dr. Parikh leads a multidisciplinary team focused on providing high-reliability, quality care with emphasis on patient experience. Her research group actively investigates cerebral hemodynamics, neuroimaging biomarkers, and clinical decision support tools for patients with acute neurological conditions, with particular attention to improving triage and interhospital transfer of neuroscience patients.
Ben Findlay serves as Senior Lecturer in Computer & Digital Forensics within the Department of Computing and Games at Teesside University, where he leads the BSc (Hons) Computer and Digital Forensics and MSc Digital Forensics and Cyber Investigation programmes. His prior career as a Digital Forensic Investigator with North Yorkshire Police involved high-profile cases including murder, child abuse, and cybercrime, providing real-world context to his academic work. He earned both his BSc (Hons) in Applied Science and Forensic Investigation and MSc in Digital Forensics from Teesside University. His research program focuses on forensic artefacts, mobile and cloud investigations, and child protection, with particular expertise in Linux systems, embedded devices, and digital policing methodologies. Analysis of his recent publications reveals a consistent trajectory toward solving practical forensic challenges in under-resourced environments, with significant contributions to Linux forensics (including thumbnail analysis and encryption access), embedded device acquisition, and standard operating procedures for law enforcement. His work bridges academic research and police practice through active consultancy and professional scheme assessments. Fellow of Higher Education Academy Member of Chartered Institute for IT (BCS) Member of Chartered Institute of Information Security (CIISec) Assessor for College of Policing's ICDIP scheme Member of Chartered Society of Forensic Sciences (CSFS) Ben supervises postgraduate research in digital forensics areas and organizes the student-led Teesside Digital Forensics Conference (TDFCon), demonstrating commitment to developing the next generation of forensic practitioners through hands-on learning experiences.
Lifeng Yu is a Professor of Medical Physics at Mayo Clinic, holding a primary appointment as Consultant in the Department of Radiology. He specializes in CT physics, radiation dose optimization, and AI-driven imaging techniques. Dr. Yu earned his PhD in Medical Physics from the University of Chicago (2006), following degrees from Beijing University (BS, 1997; MEng, 2000). His research focuses on improving CT imaging through advanced reconstruction algorithms, photon-counting detectors, and quantitative image quality metrics. He chairs key committees such as the Radiological Society of North America's Physics Committee and SPIE's Medical Imaging Conference. Awards include Fellowships from AAPM (2018) and SPIE (2023), alongside the Reese-Hartman Award (2012). His work bridges clinical translation of technologies like multi-energy CT and AI-based denoising, aiming to enhance diagnostic accuracy while reducing radiation exposure. Dr. Yu's expertise spans CT system optimization, virtual clinical trials, and standards development. He has contributed over 300 peer-reviewed publications and holds patents for innovations in CT dose management and image reconstruction.
Kevin P. Kaut is a Professor of Psychology at the University of Akron, jointly affiliated with the Biology department. He holds academic leadership roles as Chair of the Institutional Animal Care and Use Committee (IACUC) and contributor to the University of Akron Research Vivarium (UARV). His academic journey includes a Bachelor's in Psychology with Biology coursework, a Master’s in School Psychology, and a PhD in Biomedical Science (Neuroscience) from Kent State University and NEOMED. Dr. Kaut’s teaching focuses on Biological Psychology, Psychopharmacology, and Neuroscience, with specializations in neuroanatomy and behavioral neuroscience. His research spans human and animal behavior, neuropathology, and ethical issues in medical decision-making. Key areas include Chiari malformation’s impact on work and health, animal welfare, and public interest neuroscience (e.g., capital punishment ethics). He has advised numerous students across Psychology and Biology, many advancing to careers in medicine, research, and industry. His research facilities include the Auburn Science and Engineering building, where he explores topics like invertebrate learning (e.g., isopod phototaxis), neuroanatomical correlates of consciousness, and age-related cognitive changes. Despite no explicitly listed awards, his work reflects contributions to interdisciplinary neuroscience and ethical medical practice. Advising and grants: Over 25 years, Dr. Kaut has mentored diverse student projects, including studies on traumatic brain injury in athletes, pediatric Chiari malformation outcomes, and zebrafish developmental physiology. His labs emphasize translational research bridging animal models and human neuropsychological challenges.
Andrei Popescu is a Senior Lecturer in Computing Foundations at the School of Computer Science, University of Sheffield, where he also serves as School Programmes Lead (PGT). He is a member of both the Security of Advanced Systems research group and the Foundations of Computation research group. Prior to joining Sheffield in May 2020, he was a Lecturer at Middlesex University and a postdoctoral researcher at TU Munich. Dr. Popescu holds dual PhDs: one in computer science from the University of Illinois at Urbana-Champaign (advised by Elsa L. Gunter and Grigore Roșu) and another in mathematics from the University of Bucharest (advised by George Georgescu). His primary research interests include proof assistants, information flow security, inductive and coinductive datatypes, automated deduction, and syntax with bindings. His work often focuses on the formal verification of security properties in practical systems, as evidenced by projects like CoCon (a conference management system with verified confidentiality) and CoSMeDis (a social media platform with formally verified security guarantees). Analysis of his recent publications reveals a strong focus on foundational aspects of proof assistants, particularly Isabelle/HOL, with significant contributions to syntax with bindings, recursion principles, and the formalization of Gödel's incompleteness theorems. His work bridges theoretical computer science with practical applications in security verification. Scientific Awards: Distinguished paper award at POPL 2025 for 'Barendregt Convenes with Knaster and Tarski: Strong Rule Induction for Syntax with Bindings' Distinguished paper award at POPL 2024 for 'Nominal Recursors as Epi-Recursors' Distinguished paper award at POPL 2023 for 'Admissible Types-to-PERs Relativization in Higher-Order Logic' Dr. Popescu has successfully supervised PhD students, including Lorenzo Gheri whose thesis focused on syntax with bindings. He has secured significant research funding, including the COVERT project (EPSRC, £422,585), Security of Digital Twins in Manufacturing (EPSRC, £774,954), and Cyclic Reasoning Mechanisms for Interactive Theorem Proving (Royal Society, £12,000). He is actively involved in the research community, serving on program committees for major conferences including POPL, ITP, CSF, and IJCAR, and co-organizing the Midlands Graduate School. His work with the Security of Advanced Systems group continues to advance the field of formal verification for security-critical systems.
Jose Luis Cantero Lorente is a University Professor in the Department of Physiology, Anatomy and Cell Biology at Pablo de Olavide University, specializing in neuroscience with a primary focus on Alzheimer's disease and neurodegenerative disorders. His work bridges electrophysiology, neuroimaging, and biomarker discovery to understand cognitive decline in aging. Education: Doctorate from the University of Seville (1999) with thesis: "Electrophysiological characterization of alpha activity in three states of brain activation in human subjects: relaxed wakefulness, drowsiness and REM phase", supervised by Dr. Carlos María Gómez González. Research Interests: Dr. Cantero Lorente's research spans Alzheimer's Disease , Neuroscience , and Biomarkers , with emphasis on early detection mechanisms through salivary, blood, and CSF analysis. He investigates sleep-memory interactions , metabolic drivers of neurodegeneration (e.g., insulin resistance), and neuroinflammatory pathways using multimodal approaches including proteomics, lipidomics, and functional MRI. His pioneering work established salivary lactoferrin as a diagnostic tool for Alzheimer's. Publication Trends: His 2022-2025 publications reveal a strategic shift toward multimodal biomarker integration , combining amyloid-beta, tau, and metabolic markers for early Alzheimer's detection. Key themes include Parkinson's disease proteomics (e.g., candesartan neuroprotection), herpes virus-amyloid links in aging, and intracortical myelin alterations as precursors to cognitive decline. Recent work increasingly incorporates machine learning for database analysis and explores angiotensin-based neuroprotective strategies. Scientific Awards: No awards were specified in the source material. Advising and Grants: He supervises doctoral candidates in the Biotechnology, Biomedicine and Health Sciences program at Pablo de Olavide University, specifically guiding the "Early Detection of Alzheimer's Disease" track. His research is supported by Spain's PAIDI framework (Health Science and Techniques), with projects focusing on interdisciplinary audiological databases and neural network alterations in mild cognitive impairment. Labs and Teams: As leader of the LNF Functional Neuroscience research group, he directs studies on electrophysiological correlates of cognitive decline, utilizing EEG, MRI, and molecular techniques to map structural-functional brain changes in Alzheimer's progression. The group collaborates extensively on national initiatives for biomarker validation in neurodegenerative diseases.
Dr. Stephen Sansom serves as Associate Professor and Group Leader of the Computational and Single Cell Genomics Group at the University of Oxford's Kennedy Institute. His work bridges computational biology with immunology to decode inflammatory disease mechanisms through advanced genomic approaches. His academic foundation includes a BSc (Hons) in Biochemistry from the University of Dundee (2001) followed by a DPhil in Developmental Biology through the Wellcome Trust 4-year PhD programme at the University of Cambridge. Postdoctoral research at the Gurdon Institute with Dr. Rick Livesey established his expertise in genomic analysis of neural development. Dr. Sansom's research centers on computational genomics of immune processes, particularly central tolerance mechanisms and inflammatory disorders. His group pioneers single-cell genomic methodologies to dissect cellular heterogeneity in conditions like inflammatory bowel disease, rheumatoid arthritis, and atherosclerosis. Key innovations include developing frameworks for analyzing promiscuous gene expression in thymic epithelia and deconvoluting monocyte responses in immune-mediated diseases through collaborative projects with experimental immunologists. Analysis of his recent publications reveals dominant themes in macrophage biology during atherosclerosis progression, B/T cell dynamics in viral infections (including influenza and COVID-19), and stromal cell contributions to joint destruction in arthritis. His work consistently identifies novel cellular states and molecular networks driving pathogenesis, with strong emphasis on translational relevance for therapeutic targeting. Supported initially by an MRC Career Development Fellowship in Chris Ponting's CGAT program, Dr. Sansom now directs the Computational Genomics team he established at the Kennedy Institute in 2014. His collaborative model integrates computational expertise with wet-lab immunology across multiple Oxford research groups. The Sansom Group operates as the Computational and Single Cell Genomics Group within the Kennedy Institute, maintaining specialized pipelines for high-dimensional genomic data analysis. Current efforts focus on scaling single-cell multi-omics approaches to track immune cell evolution during chronic inflammation and infection.
Tormod Fladby serves as an Adjunct Professor at the University of Oslo, with primary clinical and research affiliation at Akershus University Hospital's Division of Medicine and Laboratory Sciences. His work bridges clinical neurology and dementia research, focusing on practical applications of biomarker science for improved diagnosis and monitoring of neurodegenerative conditions. Dr. Fladby's research program encompasses several critical areas in cognitive disorders: Development and validation of blood-based biomarkers for Alzheimer's disease, particularly phosphorylated tau (p-tau217) Establishment of Norwegian normative data for neuropsychological tests including D-KEFS and Rey Auditory Verbal Learning Test Investigation of relationships between amyloid pathology, tau pathology, neuroinflammation, and cognitive outcomes Studies on cognitive recovery following stroke and rehabilitation Examination of sex differences in neurodegenerative processes and biomarker expression His recent publications reveal a strong trend toward precision medicine applications in dementia diagnosis, with particular emphasis on making biomarker testing more accessible through blood-based methods. Significant work focuses on culturally appropriate cognitive assessment tools for Scandinavian populations, addressing a critical gap in dementia diagnosis. His research consistently examines how different pathological processes interact to produce cognitive symptoms, with implications for both diagnosis and treatment. Dr. Fladby actively collaborates with the Clinical Neuroscience Group at Akershus University Hospital, working within a multidisciplinary team that includes neurologists, neuropsychologists, and laboratory scientists. His work has direct clinical relevance for improving diagnostic accuracy in memory clinics and developing more effective monitoring strategies for patients with cognitive disorders.
Tyler Bold, MD, PhD serves as Associate Professor in the Division of Infectious Diseases and International Medicine within the Department of Medicine at the University of Minnesota Medical School. He concurrently holds faculty appointments in the Microbiology, Immunology and Cancer Biology (MICaB) Ph.D. Graduate Program and the Department of Medicine, establishing a multidisciplinary research presence spanning infectious disease pathogenesis, immunology, and host-pathogen interactions. His research program integrates clinical infectious disease expertise with fundamental immunological investigation, focusing on tuberculosis host-directed immunotherapy, SARS-CoV-2 pathogenesis mechanisms, and macrophage biology in atherosclerosis. Key interests include T cell costimulation in granulomatous diseases, viral-microbiome interactions during respiratory infections, and diagnostic innovations for resource-limited settings. His work bridges basic science discovery with translational clinical applications, particularly in immunocompromised populations and complex infectious syndromes. Analysis of his 15 most recent publications reveals dominant research trajectories in tuberculosis immunology (40% of articles), SARS-CoV-2 pathogenesis and therapeutics (35%), and atherosclerosis immunometabolism (15%), with emerging work on fungal infections in hematologic malignancies. The publications demonstrate consistent use of advanced techniques including single-cell resolution analysis, structural biology, and randomized clinical trials, reflecting both mechanistic depth and clinical relevance across infectious disease subspecialties.
Professor Nick Fox is a leading clinical academic in neurodegenerative diseases, currently serving as Professor of Clinical Neurology at the Queen Square Institute of Neurology, University College London . He is also Director of the Dementia Research Centre and an Honorary Consultant Neurologist at the National Hospital for Neurology and Neurosurgery. Key Affiliations: University College London Dementia Research Centre National Hospital for Neurology and Neurosurgery Research Focus: Fox is renowned for pioneering MRI-based methods to improve early detection, differential diagnosis, and progression monitoring of cognitive disorders, particularly familial dementias (Alzheimer's and frontotemporal lobar degenerations). His work integrates biomarkers, genetic analysis, and neuroimaging to assess disease-modifying therapies. Recent Publications highlight his contributions to amyloid-targeting therapies (e.g., gantenerumab, donanemab), plasma biomarker validation (p-tau181, β-synuclein), and genetic predictors of Alzheimer's onset. His studies often appear in high-impact journals like Nature , Brain , and Lancet Neurology . Scientific Awards & Appointments: Weston Brain Institute International Outstanding Achievement Award NIHR Senior Investigator Academia Europaea Member Royal College of Physicians Fellowship Teaching & Leadership: Fox contributes to UCL's MSc programs and international postgraduate courses, including the UCL-Gothenburg Biomarkers Course. He co-founded Rare Dementia Support , a network providing resources for patients with inherited cognitive disorders.
